West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 89/100

Q4 2021 West Pharmaceutical Services Inc Earnings Call Transcript

Feb 17, 2022 / 02:00PM GMT
Release Date Price: R$60.64
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q4 2021 West Pharmaceutical Services Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to turn the conference over to your speaker for today, Quintin Lai, Vice President, Investor Relations. You may begin.

Quintin J. Lai
West Pharmaceutical Services, Inc. - VP of Corporate Development, Strategy & IR

Thank you, Towanda. Good morning, and welcome to West's Fourth Quarter and Full Year 2021 Conference Call. We issued our financial results this morning, and the release has been posted in the Investors section on the company's website located at westpharma.com.

This morning, CEO, Eric Green; and CFO, Bernard Birkett, will review our financial results, provide an update on our business and present an update on our financial outlook for the full year 2022. There is a slide presentation that accompanies today's call, and a copy of that presentation is available on the Investors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot